Neonatal Alloimmune Thrombocytopenia

This is a condition that can affect newborns. It happens when the mother's immune system attacks the baby's platelets. This can cause the baby to have a low platelet count, which might lead to bleeding or bruising.

Condition

What people with Neonatal Alloimmune Thrombocytopenia report

Every report comes from a Lived member, sent anonymously.

Have you tried IVIG for Neonatal Alloimmune Thrombocytopenia?

NameHow it went

About Neonatal Alloimmune Thrombocytopenia

What It Is

Neonatal alloimmune thrombocytopenia (often shortened to NAIT, or FNAIT when it includes the fetus before birth) is a condition in which a baby has a low platelet count because the pregnant mother's immune system has made antibodies against the baby's platelets. Platelets are the blood cells that plug small breaks in blood vessels, so a baby with too few of them bleeds more easily. Many affected babies have only tiny red or purple spots on the skin (petechiae) or bruising, and some have no visible signs at all. The most serious risk is bleeding inside the brain, which often happens before birth, sometimes before 28 weeks of pregnancy. A brain bleed can be fatal or cause lasting problems with development, movement or vision. That is why this rare condition is taken seriously, even though most affected babies never have a brain bleed. It is the most common cause of severely low platelets in an otherwise healthy newborn.

Causes & Risk Factors

Platelets carry small inherited markers on their surface called human platelet antigens (HPAs). A baby inherits these markers from both parents. When the baby has a platelet antigen from the father that the mother lacks, her immune system can treat it as foreign and make antibodies against it. Those antibodies cross the placenta, attach to the baby's platelets and cause them to be destroyed. In people of European ancestry the antigen most often involved is called HPA-1a; other antigens, such as HPA-5b, and HPA-4 in people of Asian ancestry, account for other cases and often cause milder disease. Certain immune-system genes make some mothers more likely to form these antibodies. Nothing the mother did during pregnancy causes it. This condition can affect a first pregnancy. In fact, most brain bleeds happen in the first affected pregnancy, before anyone knew the family was at risk. Once a mother has made these antibodies, later babies who inherit the same antigen are at risk too. If the father carries two copies of the antigen, every child will inherit it; if he carries one copy, each child has a 50% chance.

How It's Diagnosed

Pregnancies are not routinely screened for this condition, so most cases come to light after birth, when a baby has skin spots, bruising or bleeding, or when a blood count done for another reason is low. For comparison, adults normally have 150,000 to 450,000 platelets per microliter of blood. In this condition a newborn's count is below 100,000 and often below 50,000, which is considered severe. The mother's own platelet count is usually normal, which helps set this apart from conditions in which the mother's platelets are also low. Confirming the diagnosis takes specialized laboratory testing. The mother's blood is checked for antibodies against platelet antigens, and genetic typing of the parents (and often the baby) identifies the mismatch. Clinicians also consider other causes of low platelets in a newborn, such as infection. Because a brain bleed may cause no outward signs, a newborn suspected of having this condition should have the brain checked with imaging, usually ultrasound and sometimes MRI, as soon as possible, whatever the platelet count. In a family with an affected child, the father's genetic typing, or a test of the mother's blood that analyzes fetal DNA, can show whether a new pregnancy has inherited the antigen.

Treatment Options

For an affected newborn, the main treatment is a platelet transfusion when the count is very low or the baby is bleeding. Platelets from donors who lack the problem antigen work best, but treatment should not wait for them, because ordinary donor platelets can raise the count in the meantime. Current recommendations suggest a transfusion when the count falls below about 25,000 per microliter, or below 50,000 if an earlier child had a brain bleed, with higher targets for a baby who is actively bleeding. Intravenous immunoglobulin (IVIG), a product made from antibodies pooled from blood donors, is sometimes added, but experts disagree about whether it helps after birth, and it is not used on its own. The count often keeps falling for a few days after birth, so it is checked frequently until it is stable. In a later pregnancy, the goal is to prevent a brain bleed before birth, and care is led by a maternal-fetal medicine team at a specialized center. The usual approach is weekly IVIG infusions given to the mother, starting around 12 to 16 weeks if a previous child had a brain bleed and around 20 to 24 weeks otherwise. In published studies, brain bleeds were rare in pregnancies treated this way. The evidence comes mostly from small trials without an untreated comparison group, and some experts question whether the benefit outweighs the weekly burden when no earlier child had a brain bleed. IVIG is not specifically approved for this use. Common side effects are headache, nausea and itching or rash. Adding a steroid such as prednisone is debated. Older approaches that sampled the fetus's blood and transfused platelets in the womb are now largely avoided because of their complication rate. Delivery is planned at a center that can provide matched platelets and specialized newborn care. Forceps, vacuum delivery and electrodes placed on the baby's scalp during labor are avoided. When a previous child had a brain bleed, a planned cesarean around 36 to 37 weeks is often preferred; otherwise, vaginal birth around 37 to 38 weeks may be reasonable.

What to Expect

After birth, the baby's platelet count is followed with repeated blood tests. It may drop for a few days before improving, and occasionally it stays low for 8 to 12 weeks. A count that stays low longer than expected leads doctors to look for another cause, such as an inherited platelet disorder. The longer-term outlook depends mainly on whether a brain bleed occurred and how large it was. Children who had a significant brain bleed may need ongoing care for developmental delay, seizures, vision problems or cerebral palsy. Research also suggests that children diagnosed with this condition have a higher risk of developmental or learning problems later, ranging from mild to severe, even when no brain bleed was found, so developmental check-ups with the pediatrician are worthwhile. The diagnosis often arrives suddenly, and parents frequently describe a stressful search for answers. In one study, more than half of affected mothers reported anxiety, depression or sleep problems lasting beyond six weeks. Family planning changes too: knowing the father's platelet type before another pregnancy shows how likely future children are to be affected, and an affected pregnancy usually means weekly infusions and a planned delivery at a specialized center.

When to Seek Help

If you have had a baby with this condition, tell your obstetric team as soon as you are pregnant again, or ideally before trying, so you can be referred to a specialist center; in the highest-risk pregnancies, treatment may start as early as 12 weeks. A newborn who develops tiny red or purple pinpoint spots, unexplained bruising, or blood in the stool or urine needs prompt medical evaluation, including a platelet count. If your baby has already been diagnosed and you notice new spots, bruising or bleeding after going home, call the care team right away.

Questions to Ask Your Doctor

  1. 1.Which platelet antigen was involved for our family, and what does the father's typing mean for the chance that a future child is affected?
  2. 2.Has my baby's brain been checked for bleeding, and what follow-up imaging or developmental check-ups do you recommend?
  3. 3.What platelet count are we aiming for, and how often will it be checked until it recovers?
  4. 4.If I become pregnant again, which specialist center should manage the pregnancy, and when would IVIG need to start?
  5. 5.Should my sisters or other relatives be told about this diagnosis before they have children?

Last reviewed • Oct 2026

Educational content, not medical advice.